Vor Bio (VOR) announced the appointment of Sandy Mahatme as CFO and chief business officer, effective July 9. Mahatme joins Vor Bio with more than 30 years of executive leadership experience in the biopharmaceutical industry. He most recently served as president, COO, and CFO of National Resilience.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR: